New view of tumors’ evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Study reveals immune cells that are critical to combating the parasite in early stages of infection.
MIT is one of six institutions receiving a total of $540 million to provide reliable, long-term support for high-impact, innovative research.
Studying these cells could lead to new treatments for diseases ranging from gastrointestinal disease to diabetes.
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.
MIT researchers find a way to boost lithium-air battery performance, with the help of modified viruses.
Simple urine test developed by MIT engineers uses nanotechnology to detect dangerous blood clotting.
Mice with human immune cells help researchers discover how the mosquito-borne virus depletes blood platelets.
Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases.
Engineered liver tissue developed at MIT could help scientists test new drugs and vaccines.
David Benjamin will investigate mechanisms that melanoma cells use to spread to distant sites throughout the body
Researchers identify compounds that help liver cells grow outside the body.
Findings may offer a new way to kill cancer cells by forcing them into an alternative programmed-death pathway.
MIT’s Sangeeta Bhatia is part of the research team funded by the $6 million DARPA grant.
New study measures physical changes in tumor cells as they become metastatic.